Glucocorticoid influence on tyrosine hydroxylase activity in mouse locus coeruleus during postnatal development
- PMID: 6127203
- DOI: 10.1210/endo-111-5-1519
Glucocorticoid influence on tyrosine hydroxylase activity in mouse locus coeruleus during postnatal development
Abstract
Administration of corticosterone (10 mg/kg, ip, twice daily for 3 days) to mice during the second week of postnatal development led to an increase of tyrosine hydroxylase (TH) activity in the locus coeruleus, but not in the substantia nigra. The corticosterone effect was observed only transiently during this developmental period. Tritiated corticosterone can bind to a cytosol fraction prepared from mouse locus coeruleus, with a specific binding capacity of 110 fmol/mg protein. There is a correlation between the ability of various steroids to increase TH activity and their binding to the cytosol glucocorticoid receptor. Cortexolone and progesterone, two antiglucocorticoids that can bind to the cytosol receptor, were found to abolish the effect of corticosterone in increasing TH activity. It appears that the noradrenergic neurons in the locus coeruleus may be target cells for glucocorticoids, and that the glucocorticoid effect on TH may be a receptor-mediated mechanism.
Similar articles
-
Influence of ACTH on tyrosine hydroxylase activity in the locus coeruleus of mouse brain.Neuroendocrinology. 1984 Apr;38(4):269-75. doi: 10.1159/000123902. Neuroendocrinology. 1984. PMID: 6145110
-
Glucocorticoid status affects antidepressant regulation of locus coeruleus tyrosine hydroxylase and dorsal raphé tryptophan hydroxylase gene expression.Brain Res. 2009 Sep 8;1288:69-78. doi: 10.1016/j.brainres.2009.06.082. Epub 2009 Jul 3. Brain Res. 2009. PMID: 19577549 Free PMC article.
-
Cytosol glucocorticoid binding in monoaminergic cell groups.Dev Neurosci. 1982;5(5-6):458-64. doi: 10.1159/000112706. Dev Neurosci. 1982. PMID: 7160311
-
Bisphenol A exposure disrupts the development of the locus coeruleus-noradrenergic system in mice.Neuropathology. 2014 Dec;34(6):527-34. doi: 10.1111/neup.12137. Epub 2014 Jul 2. Neuropathology. 2014. PMID: 24985408
-
Development of glucocorticoid antagonists.Pharmacol Ther. 1983;20(2):263-81. doi: 10.1016/0163-7258(83)90041-4. Pharmacol Ther. 1983. PMID: 6351112 Review. No abstract available.
Cited by
-
Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.Acta Neuropathol. 2014 Apr;127(4):477-94. doi: 10.1007/s00401-014-1255-5. Epub 2014 Feb 8. Acta Neuropathol. 2014. PMID: 24509835 Free PMC article.
-
MicroRNAs 29b and 181a down-regulate the expression of the norepinephrine transporter and glucocorticoid receptors in PC12 cells.J Neurochem. 2016 Oct;139(2):197-207. doi: 10.1111/jnc.13761. Epub 2016 Sep 22. J Neurochem. 2016. PMID: 27501468 Free PMC article.
-
Potential programming of dopaminergic circuits by early life stress.Psychopharmacology (Berl). 2011 Mar;214(1):107-20. doi: 10.1007/s00213-010-2085-3. Epub 2010 Nov 19. Psychopharmacology (Berl). 2011. PMID: 21088961 Review.
-
Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission.Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15445-50. doi: 10.1073/pnas.93.26.15445. Proc Natl Acad Sci U S A. 1996. PMID: 8986831 Free PMC article.
-
Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.J Neural Transm Gen Sect. 1991;85(3):195-210. doi: 10.1007/BF01244945. J Neural Transm Gen Sect. 1991. PMID: 1930881
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources